guest ::
| Home > Publications database > Integrative genomic and transcriptomic analysis of leiomyosarcoma. > print |
| Home > Publications database > Integrative genomic and transcriptomic analysis of leiomyosarcoma. > print |
| 001 | 131775 | ||
| 005 | 20240229105012.0 | ||
| 024 | 7 | _ | |a 10.1038/s41467-017-02602-0 |2 doi |
| 024 | 7 | _ | |a pmid:29321523 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC5762758 |2 pmc |
| 024 | 7 | _ | |a altmetric:31493509 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2018-00072 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 500 |
| 100 | 1 | _ | |a Chudasama, Priya |0 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |b 0 |e First author |
| 245 | _ | _ | |a Integrative genomic and transcriptomic analysis of leiomyosarcoma. |
| 260 | _ | _ | |a London |c 2018 |b Nature Publishing Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1659606982_16657 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Leiomyosarcoma (LMS) is an aggressive mesenchymal malignancy with few therapeutic options. The mechanisms underlying LMS development, including clinically actionable genetic vulnerabilities, are largely unknown. Here we show, using whole-exome and transcriptome sequencing, that LMS tumors are characterized by substantial mutational heterogeneity, near-universal inactivation of TP53 and RB1, widespread DNA copy number alterations including chromothripsis, and frequent whole-genome duplication. Furthermore, we detect alternative telomere lengthening in 78% of cases and identify recurrent alterations in telomere maintenance genes such as ATRX, RBL2, and SP100, providing insight into the genetic basis of this mechanism. Finally, most tumors display hallmarks of 'BRCAness', including alterations in homologous recombination DNA repair genes, multiple structural rearrangements, and enrichment of specific mutational signatures, and cultured LMS cells are sensitive towards olaparib and cisplatin. This comprehensive study of LMS genomics has uncovered key biological features that may inform future experimental research and enable the design of novel therapies. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Mughal, Sadaf Shabbir |0 P:(DE-He78)3ad0b83338ba5df15b5701e181f58129 |b 1 |e First author |
| 700 | 1 | _ | |a Sanders, Mathijs A |b 2 |
| 700 | 1 | _ | |a Hübschmann, Daniel |0 P:(DE-HGF)0 |b 3 |e First author |
| 700 | 1 | _ | |a Chung, Inn |0 P:(DE-He78)d1a346df2019a0c0fd79b4808e502cee |b 4 |
| 700 | 1 | _ | |a Deeg, Katharina |0 P:(DE-He78)307c43dc6b7bbf6ca6c8a29fdeb01851 |b 5 |
| 700 | 1 | _ | |a Wong, Siao-Han |0 P:(DE-He78)76f5d947149185d77a1fa1a114b3fb30 |b 6 |
| 700 | 1 | _ | |a Rabe, Sophie |0 P:(DE-He78)022daadde115569e96596dfcd21190a3 |b 7 |
| 700 | 1 | _ | |a Hlevnjak, Mario |0 P:(DE-He78)aa1da4918a48503d125ee3325c7f135e |b 8 |
| 700 | 1 | _ | |a Zapatka, Marc |b 9 |
| 700 | 1 | _ | |a Ernst, Aurélie |0 P:(DE-He78)509fb81813c1911954da583129e8ea57 |b 10 |
| 700 | 1 | _ | |a Kleinheinz, Kortine |b 11 |
| 700 | 1 | _ | |a Schlesner, Matthias |b 12 |
| 700 | 1 | _ | |a Sieverling, Lina |0 P:(DE-He78)a82e5b3870b674f83ff39df31c487ac7 |b 13 |
| 700 | 1 | _ | |a Klink, Barbara |0 0000-0002-8753-8238 |b 14 |
| 700 | 1 | _ | |a Schröck, Evelin |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Hoogenboezem, Remco M |b 16 |
| 700 | 1 | _ | |a Kasper, Bernd |b 17 |
| 700 | 1 | _ | |a Heilig, Christoph E |b 18 |
| 700 | 1 | _ | |a Egerer, Gerlinde |b 19 |
| 700 | 1 | _ | |a Wolf, Stephan |0 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb |b 20 |
| 700 | 1 | _ | |a von Kalle, Christof |0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |b 21 |
| 700 | 1 | _ | |a Eils, Roland |0 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0 |b 22 |u dkfz |
| 700 | 1 | _ | |a Stenzinger, Albrecht |0 P:(DE-HGF)0 |b 23 |
| 700 | 1 | _ | |a Weichert, Wilko |0 P:(DE-He78)891da714b7f7991d9c4c1d5224c991e7 |b 24 |u dkfz |
| 700 | 1 | _ | |a Glimm, Hanno |0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |b 25 |
| 700 | 1 | _ | |a Gröschel, Stefan |0 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f |b 26 |
| 700 | 1 | _ | |a Kopp, Hans-Georg |b 27 |
| 700 | 1 | _ | |a Omlor, Georg |b 28 |
| 700 | 1 | _ | |a Lehner, Burkhard |b 29 |
| 700 | 1 | _ | |a Bauer, Sebastian |0 P:(DE-HGF)0 |b 30 |
| 700 | 1 | _ | |a Schimmack, Simon |b 31 |
| 700 | 1 | _ | |a Ulrich, Alexis |b 32 |
| 700 | 1 | _ | |a Mechtersheimer, Gunhild |b 33 |
| 700 | 1 | _ | |a Rippe, Karsten |b 34 |
| 700 | 1 | _ | |a Brors, Benedikt |b 35 |
| 700 | 1 | _ | |a Hutter, Barbara |b 36 |
| 700 | 1 | _ | |a Renner, Marcus |b 37 |
| 700 | 1 | _ | |a Hohenberger, Peter |b 38 |
| 700 | 1 | _ | |a Scholl, Claudia |0 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |b 39 |
| 700 | 1 | _ | |a Fröhling, Stefan |0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |b 40 |e Last author |
| 773 | _ | _ | |a 10.1038/s41467-017-02602-0 |g Vol. 9, no. 1, p. 144 |0 PERI:(DE-600)2553671-0 |n 1 |p 144 |t Nature Communications |v 9 |y 2018 |x 2041-1723 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:131775 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)3ad0b83338ba5df15b5701e181f58129 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)d1a346df2019a0c0fd79b4808e502cee |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)307c43dc6b7bbf6ca6c8a29fdeb01851 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)76f5d947149185d77a1fa1a114b3fb30 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)022daadde115569e96596dfcd21190a3 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)aa1da4918a48503d125ee3325c7f135e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)509fb81813c1911954da583129e8ea57 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)a82e5b3870b674f83ff39df31c487ac7 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)891da714b7f7991d9c4c1d5224c991e7 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 30 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 39 |6 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 40 |6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Translational cancer research |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NAT COMMUN : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)G100-20160331 |k G100 |l Translationale Onkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)G200-20160331 |k G200 |l Angewandte Bioinformatik |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B080-20160331 |k B080 |l Theoretische Bioinformatik |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)B240-20160331 |k B240 |l Bioinformatik und Omics Data Analytics |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)B060-20160331 |k B060 |l B060 Molekulare Genetik |x 4 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 5 |
| 920 | 1 | _ | |0 I:(DE-He78)L301-20160331 |k L301 |l DKTK Dresden |x 6 |
| 920 | 1 | _ | |0 I:(DE-He78)W190-20160331 |k W190 |l Hochdurchsatz-Sequenzierung |x 7 |
| 920 | 1 | _ | |0 I:(DE-He78)G240-20160331 |k G240 |l Molekulare Leukämogenese |x 8 |
| 920 | 1 | _ | |0 I:(DE-He78)L701-20160331 |k L701 |l DKTK München |x 9 |
| 920 | 1 | _ | |0 I:(DE-He78)G250-20160331 |k G250 |l Molekulare Therapie in der Hämatologie und Onkologie |x 10 |
| 920 | 1 | _ | |0 I:(DE-He78)L801-20160331 |k L801 |l DKTK Tübingen |x 11 |
| 920 | 1 | _ | |0 I:(DE-He78)L401-20160331 |k L401 |l DKTK Essen |x 12 |
| 920 | 1 | _ | |0 I:(DE-He78)G102-20160331 |k G102 |l Angewandte Funktionelle Genomik |x 13 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G100-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G200-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B080-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B240-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B060-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L301-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W190-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G240-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L701-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G250-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L801-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L401-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G102-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|